Prof Richard Edmondson

Clinical Prof in Gynaecological Oncology

View graph of relations


Richard Edmondson qualified in medicine from Newcastle University in 1992 and after a year of surgical training in New Zealand undertook speciality training in the Northern Deanery in Obstetrics and Gynaecology with subspecialty training in Gynaecological Oncology at the Queen Elizabeth Hospital, Gateshead. He was awarded an MD from Newcastle University in 2002 for his work investigating the biology of the ovarian surface epithelium which led to his interest in ovarian cancer.


He was appointed as a consultant in Gateshead and honorary senior lecturer in Newcastle in 2005 and in January 2014 he took up the chair of Gynaecological Oncology at the University of Manchester.


His research focuses on developing personalised treatments for patients with advanced. In addition to developing personalised treatment algorithms to predict outcomes to surgery he leads a translational programme of research using ex vivo modelling of ovarian cancer to investigate how the DNA damage response can be used to develop potential therapeutic biomarkers. His group has developed techniques to establish real time models for ex vivo testing of drug sensitivity alongside functional assessment of the tumour and this has led to exciting developments in the ability to predict response to novel agents including PARP inhibitors as well as conventional chemotherapy agents such as carboplatin.


Biology, Medicine and Health (BMH) Domains

Related information